Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
STADA Australia is the regional subsidiary of STADA Arzneimittel AG, a leading global pharmaceutical company headquartered in Germany. The company operates across three strategic segments: Consumer Healthcare, Generics, and Specialty Pharmaceuticals, providing a diverse range of high-quality medical products to the Australian market. Its specialty portfolio is notably focused on neurology, particularly advanced treatments for Parkinson's disease, and an expanding range of biosimilars in immunology and ophthalmology. STADA Australia has significantly grown its presence through strategic acquisitions of well-known consumer brands and partnerships with global biotech firms. The company is dedicated to its purpose of "Caring for People's Health as a Trusted Partner" by ensuring broad access to essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on STADA Pharmaceuticals Australia.